Medicine details
Image | |
Name | Delipid |
Dosage | Capsule |
Generic Name | Gemfibrozil |
Classes |
Metabolic Agent Antihyperlipidemic/Lipid Lowering Agent Fibric Acid Derivative |
Diseases |
Cardiovascular Disease High Cholesterol |
Company | Square Pharmaceuticals Ltd. |
Drug Package Details
Strength | 300 mg |
Storage Condition | |
Origin Country | Bangladesh |
Commercial Pack | 30 |
Price per pack | ৳ 210.90 |
Cost per pack | ৳ 0.00 |
Package unit | 10 caps strip |
Price per unit | ৳ 0.00 |
Cost per unit | ৳ 0.00 |
Discount | 0 |
Coupon | |
Remarks |
Gemfibrozil
Gemfibrozil is a lipid regulating agent which decreases serum triglycerides and very low density lipoprotein (VLDL) cholesterol, and increases high density lipoprotein (HDL) cholesterol.
Gemfibrozil is indicated for the following conditions-
- Primary hyperlipidemia
- Prevention of coronary heart diseases
The recommended dose for adults is 1200 mg administered in two divided doses 30 minutes before the morning and evening meal.
- Laboratory studies should be done to ascertain that the lipid levels are consistently abnormal. Before instituting Gemfibrozil therapy, every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities.
- The risk of myopathy and rhabdomyolysis is increased with combined gemfibrozil and HMG-CoA reductase inhibitor therapy.
- Caution should be exercised when anticoagulants are given in conjunction with Gemfibrozil. The dosage of the anticoagulant should be reduced to maintain the prothrombin time at the desired level to prevent bleeding complications. Frequent prothrombin determinations are advisable until it has been definitely determined that the prothrombin level has stabilized.
Contraindication
Gemfibrozil is contraindicated in-
- Hypersensitivity to gemfibrozil.
- Combination therapy of gemfibrozil with repaglinide.
Gemfibrozil is contraindicated in the following health conditions-
- Severe kidney problems
- Severe liver problems (including primary biliary cirrhosis)
- Preexisting gallbladder disease